As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That… The post Expert Insights: How Targeted Protein Degraders are Advancing Oncology Drug Development with Dr. Blythe Thomson appeared first on Medpace Corporate .